Correction: Pyrotinib promotes the antitumor effect of T-DM1 by increasing drug endocytosis in HER2-positive breast cancer.
0/5 보강
APA
Ren W, Liu J, et al. (2026). Correction: Pyrotinib promotes the antitumor effect of T-DM1 by increasing drug endocytosis in HER2-positive breast cancer.. Scientific reports, 16(1), 3062. https://doi.org/10.1038/s41598-026-36768-9
MLA
Ren W, et al.. "Correction: Pyrotinib promotes the antitumor effect of T-DM1 by increasing drug endocytosis in HER2-positive breast cancer.." Scientific reports, vol. 16, no. 1, 2026, pp. 3062.
PMID
41577984 ↗
같은 제1저자의 인용 많은 논문 (4)
- A Murine Database of Structural Variants Identifies A Candidate Gene for a Spontaneous Murine Lymphoma Model.
- Malignant effusions serve as a feasible source for therapy-related biomarker testing in advanced gastric cancer.
- Lactobacillus plantarum liver abscess following ERCP: a case report and review.
- Causal Associations Between the Presence of Prostate Cancer or Testosterone Levels and Bladder Cancer Risk: A Mendelian Randomization Study.
📖 전문 본문 읽기 PMC JATS · ~0 KB · 영문
Correction to: Scientific Reports 10.1038/s41598-025-03678-1, published online 28 May 2025
The original version of this Article contained an error in the order of the author names, which was incorrectly given as Wenjun Ren, Tienian Zhu, Jiankun Liu, Ruijing Zhao, Fei Zhao, Yimei Zhang & Jianping Mu.
The original Article has been corrected.
The original version of this Article contained an error in the order of the author names, which was incorrectly given as Wenjun Ren, Tienian Zhu, Jiankun Liu, Ruijing Zhao, Fei Zhao, Yimei Zhang & Jianping Mu.
The original Article has been corrected.
출처: PubMed Central (JATS). 라이선스는 원 publisher 정책을 따릅니다 — 인용 시 원문을 표기해 주세요.